Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec 1;173(11):946-947.
doi: 10.7326/L20-1274.

Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence

Affiliations
Comment

Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence

Wenjun Deng et al. Ann Intern Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-3583.

Comment on

References

    1. Tobis JM, Charles A, Silberstein SD, et al. Percutaneous closure of patent foramen ovale in patients with migraine: the PREMIUM trial. J Am Coll Cardiol. 2017;70:2766–74. [PMID: 29191325] doi:10.1016/j.jacc.2017.09.1105 - DOI - PubMed
    1. Silvestry FE, Cohen MS, Armsby LB, et al. Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen ovale: from the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr. 2015;28:910–58. [PMID: 26239900] - PubMed
    1. Deng W, Beecher C, Burant C, et al. Metabolomic analysis of PFO-related stroke shows immediate and persistent decrease of homocysteine post PFO closure. Neurology. 2015;84(14 Suppl):P2.277.
    1. Elmariah S, Furlan AJ, Reisman M, et al.; CLOSURE I Investigators. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex septal closure system in patients with a stroke and/or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale) trial. JACC Cardiovasc Interv. 2014;7:913–20. [PMID: 25147037] doi:10.1016/j.jcin.2014.01.170 - DOI - PubMed
    1. Liu K, Song B, Palacios IF, et al. Patent foramen ovale attributable cryptogenic embolism with thrombophilia has higher risk of recurrence and responds to closure. JACC Cardiovasc Interv. 2020. [Forthcoming]. - PMC - PubMed